Efficacy of Cyclophosphamide and Mycophenolate Mofetil Based Induction Therapy in Egyptian Patients with Systemic Lupus Erythematosus-associated Nephritis
European Journal of Molecular & Clinical Medicine,
2021, Volume 8, Issue 2, Pages 2672-2679
AbstractBackground: Lupus nephritis (LN) is a serious manifestation of systemic lupus erythematosus. Induction immunosuppression can include high dose cyclophosphamide (NIH protocol), low dose cyclophosphamide (Euro-lupus protocol) or mycophenolate mofetil (MMF). We aimed to assess the efficacy and safety of the 3 induction regimens in
Egyptian patients with LN.
- Article View: 187
- PDF Download: 322